Home›Companies›Healthcare›Septablate

Septablate, Inc.

Develops a heart treatment for patients whose anatomy excludes them from existing therapies.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 11, 2026·Suggest an edit

About Septablate

Septablate is a private company based in Minnetonka, Minnesota, incorporated in 2026 in Delaware. It has reported $1,000,000 raised in one offering on Form D since September 2026. Its chief executive is Peter DeLange.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 28, 2026Sep 11, 2026$1,000,000of $4.5M target2$500KSimple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Septablate's Form D filed Sep 11, 2026.

PD
Peter DeLange
Co-founder & CEO, director
Also an executive officer at Aria CV.
TM
Thomas McPeak
Co-founder & CTO, director

Sources

  1. SECSeptablate, Inc. filing history